CHLA Clinical Research Studies
Having volunteers participate in research studies and clinical trials is critical to our research efforts. Thousands of children and families are involved in our patient-centered studies every year. Many of the treatments used today are based on the results of past research studies and clinical trials conducted with our patients. Our scientific and clinical experts take the best ideas from the laboratory -- to the patient -- in the form of promising new treatments.
By searching our study directory, you may identify research that could impact the life of your child or of another child you know. Because the number of available research studies and clinical trials for children nationwide is small, every participant makes a significant contribution.
In addition to enrolling children with certain diseases in order to study treatments and prevention of those diseases, we also need to study healthy children. Ask your child’s doctor about volunteer study options that may be suitable for your child.
Please contact the study staff listed in your search results for more information.
Back to the full listing
|Study Details - ID: CHLA-17-00542|
Dupilumab (Dupixent) for severe eczema in infants
|Full Title of Study:|
A PHASE 2/3 STUDY INVESTIGATING THE PHARMACOKINETICS, SAFETY, AND EFFICACY OF DUPILUMAB IN PATIENTS AGED ≥6 MONTHS TO <6 YEARS WITH SEVERE ATOPIC DERMATITIS
|Phase/Type of Study:|
|Purpose of Research:|
To find out safety and effectiveness of dupilumab (Dupixent) in infants with severe eczema
AGED ≥6 MONTHS TO <6 YEARS WITH SEVERE ATOPIC DERMATITIS (eczema) that is not responsive to steroids
8 weeks with 8 visits. Compensation provided.
Peck Ong, MD
|Coordinator Contact Name:|
Sydney Brown or Janet Jaime
323-361-2501 or 323-361-4537
email@example.com or firstname.lastname@example.org
|Clinical Trials .Gov Identifier:NCT03346434|